Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BGMA Lines Up New Leadership With Change Of Vice-Chair

Sandoz UK Head Diane DiGangi Trench Will Become Chair Of British Body Next Year

Executive Summary

UK generics and biosimilars industry association the BGMA is laying the groundwork for new leadership after appointing Sandoz UK head Diane DiGangi Trench as its vice-chair, ahead of her moving up to chair next year.

You may also be interested in...

Legal Challenge Could Put UK Drug Pricing Deal At Risk

The body representing generics and biosimilars companies in the UK is seeking a seat at the table as negotiations on a new voluntary price scheme get under way.

UK Generics Body Opens Rift With Government And Originators Over Rebate Scheme

By launching a bid for judicial review of its exclusion from UK negotiations over the VPAS rebate scheme, the BGMA has thrust itself into conflict with the country’s government as well as local brand industry association the ABPI.

Latest UK Rebate Rate Pushes Profit Out Of Portfolios

The UK government’s announcement of a 26.5% VPAS rate for 2023 “will make some products lossmaking,” the BGMA has cautioned, expressing serious concerns for the branded generics and biosimilars sector as it points to the risk of shortages, higher prices and fewer launches in the UK.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts